The human chromosome 22-located genes and malignancies of the central nervous system. 1996

J P Dumanski
Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.

The human chromosome 22 displays an unusual concentration of medically relevant genes, especially gene(s) involved in malignancies of the central nervous system. A full genomic and transcriptional characterization of this autosome will no doubt make a strong impact on the understanding of some of the processes which lead to the development of these tumours.

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D002904 Chromosomes, Human, 21-22 and Y The short, acrocentric human chromosomes, called group G in the human chromosome classification. This group consists of chromosome pairs 21 and 22 and the Y chromosome. Chromosomes G,Group G Chromosomes,Chromosomes, Human, 21 22,Chromosomes, Human, 21-22,Chromosome, Group G,Chromosomes, Group G,Group G Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016515 Genes, Neurofibromatosis 2 Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2. Genes, nf2,Neurofibromatosis 2 Genes,nf2 Genes,Genes, nf 2,Gene, Neurofibromatosis 2,Gene, nf 2,Gene, nf2,Neurofibromatosis 2 Gene,nf 2 Gene,nf 2 Genes,nf2 Gene
D016543 Central Nervous System Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges. CNS Neoplasm,CNS Neoplasms,Central Nervous System Neoplasm,Central Nervous System Tumor,Neoplasms, Central Nervous System,Primary Central Nervous System Neoplasm,Central Nervous System Neoplasms, Primary,Central Nervous System Tumors,Primary Central Nervous System Neoplasms,Tumors, Central Nervous System,Neoplasm, CNS,Neoplasms, CNS

Related Publications

J P Dumanski
January 2017, Handbook of clinical neurology,
J P Dumanski
July 1988, Nucleic acids research,
J P Dumanski
August 2012, Hematology/oncology clinics of North America,
J P Dumanski
May 2003, Revue neurologique,
J P Dumanski
June 2006, IDrugs : the investigational drugs journal,
J P Dumanski
December 1990, New York state journal of medicine,
J P Dumanski
November 2014, Clinical cancer research : an official journal of the American Association for Cancer Research,
J P Dumanski
January 2015, Advances in experimental medicine and biology,
J P Dumanski
August 2006, Journal of the neurological sciences,
J P Dumanski
January 2002, Internal medicine journal,
Copied contents to your clipboard!